CINGAL
CINGAL works by combining Anika’s proprietary cross-linked hyaluronic acid formulation (MONOVISC) with a well-established FDA approved steroid (Triamcinolone Hexacetonide).
Description
- The first and only hyaluronic acid plus corticosteroid combination CE approved therapy for the pain of OA
- Single-injection treatment
- Proven effects through 6 months while steroid provides fast short-term pain relief within days of injection
- Highly concentrated, non-animal based HA
- Strong safety profile in both an initial injection as well as a repeat injection
- Indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics (e.g. acetaminophen)
- For additional information please visit Anika Therapeutics’ website about CINGAL: www.cingal.com
INFORMATION
INFORMATION
